Title : Transscleral cyclophotocoagulation with diode laser in the treatment of refractory glaucoma : Tolerance and efficacy
The management of refractory glaucoma remains a challenge for the ophthalmologist today. Despite a literature rich in clinical studies, there is no consensus for its management.The multitude of possible treatments undoubtedly reflects the complexity and etiological heterogeneity of this pathology.
The objective of this work is to evaluate the effect of cyclophotocoagulation on intraocular pressure (IOP), visual acuity, the number of medications and the main complications in patients with refractory glaucoma through a series of cases.
Materials and Methods:
It was a series of 60 cases, carried out at the CHU mohammed VI of oujda. between May 2018 and FEBRUARY 2020.
The parameters studied were:
Intraocular pressure (IOP), visual acuity,the number of eye drops and Complications as well as postoperative pain assessment.
Our series includes 40 women and 20 men with an average age of 62.5 years. All patients presented with eye pain during their preoperative consultation. The etiologies of glaucoma were divided into 4 groups:
- Neovascular glaucoma: 60%
- Secondary glaucoma by angle closure: 16.66%
- Congenital glaucoma: 10%
- Uveitic glaucoma: 13.33%
Preoperatively, the mean intraocular pressure was 44.5 mmHg. All patients were on maximum hypotonic therapy. The postoperative intraocular pressure was significantly lower. Pain was controlled in all of our patients.in our series we did not find any complications.
Technical progress in the use of lasers in ophthalmology has led to considerable therapeutic benefits, relegating the oldest methods of cyclodestruction to the background. It is necessary to be able to explore the results in the very long term, but the currently demonstrated efficacy, associated with low iatrogenicity, may lead us to reflect on a possible extension of the indications of transscleral cycloweakening with diode laser, especially on less severe glaucoma?